Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
AYTU BIOPHARMA, INC (AYTU)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/16/2023 |
SC 13D/A
| Nantahala Capital Management, LLC reports a 19.7% stake in AYTU BIOPHARMA, INC. |
09/01/2021 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 4.9% stake in Aytu BioPharma, Inc. |
08/31/2021 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 5.3% stake in Aytu BioPharma, Inc. |
04/29/2020 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 0.4% stake in Aytu Bioscience, Inc. |
04/08/2020 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 5.3% stake in Aytu Bioscience, Inc. |
03/13/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/20/2020 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 40% stake in Aytu Bioscience, Inc. |
11/07/2019 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 40% stake in Aytu Bioscience, Inc. |
10/16/2019 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 40% stake in Aytu Bioscience, Inc. |
09/18/2019 |
SC 13D/A
| ARMISTICE CAPITAL, LLC reports a 40% stake in Aytu Bioscience, Inc. |
|
|